Radsafers' Comments on FDA draft guidance re: KI as a thyroid blocking agent

[Jodi.Strzelczyk@UCHSC.edu]

Thanks Jim (Hardeman) for being the first to post information on the
availability of this draft guidance .Those of us who are truly interested in
this topic can and do appreciate the fact that this very much needed
guidance has been issued. This has not been an insignificant undertaking.
One needs to bear in mind difficulties in preparing such a document (so many
different aspects need to be considered), and its noble purpose. We must
also remember that this is only a draft, distributed for comments only.
Comments, particularly on alleged inconsistencies (?!), should be addressed
directly to the FDA.

Jodi Strzelczyk
Assistant Professor, Radiological Sciences
University of Colorado, HSC, School of Medicine

************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html